European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.89% to 1,323.86 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Grifols (GRFS) and petroleum refiner Equinor (EQNR), which rose 6% and 3.9% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biotech firm BioNTech (BNTX), which were up 2.7% and 1.7% respectively.
The decliners from continental Europe were led by biopharmaceutical companies Genfit (GNFT) and Cellectis (CLLS), which fell 9.7% and 4% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (EDAP), which dropped 2.9% and 2.1% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and insurance provider Prudential (PUK), which increased 7.1% and 2.5% respectively. They were followed by communications company WPP (WPP) and cruise line operator Carnival (CUK), which rose 1.6% and 1.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and biotech firm Trinity Biotech (TRIB), which tumbled 13% and 10% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Amarin (AMRN), which lost 4.4% and 3.9% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。